Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Methods-for-preparation-of-vaccines-against-cancer

 Process for the synthesis of oligomeric compounds
What is claimed is: 1. A method for the preparation of an oligomeric compound having a moiety of F...


 Process for oligonucleotide synthesis
OF THE PREFERRED EMBODIMENTS The present invention is directed to methods for linking a ...


 Derivatized oligonucleotides having improved uptake and other properties
OF THE INVENTION Antisense therapeutics can be practiced in a variety of organisms ranging from ...


 Process for the synthesis of oligomeric compounds
What is claimed is: 1. A compound having the formula: ##STR38## wherein: X.sub.4 is Z or H; Z is CN,...


 Processes for the synthesis of oligomeric compounds
OF PREFERRED EMBODIMENTS The present invention provides methods for the preparation of oligomeric ...


 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
OF THE INVENTION Usually, in the method of synthesis of the radiolabelled platinum ...


 Pharmaceutical composition for diabetic neuropathy
What is claimed is: 1. A method for the prophylaxis of diabetic peripheral neuropathy, which ...


 Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
This invention aids in fulfilling this need in the art by providing an in vitro, single cycle, ...


 Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance
OF THE INVENTION The present invention relates to new and useful methods including methods for ...


 Continuous process for ethanol production by bacterial fermentation
The accompanying FIGURE will provide a background for the following discussion in which the method ...


 Methods for preparation of vaccines against cancer

Details
Inventors: Srivastava, Pramod K.;
Assignee: Fordham University (Bronx, NY)
Primary Examiner: Bansal; Geetha P.
Assistant Examiner:
Attorney, Agent or Firm: Pennie & Edmonds LLP

The present invention relates to methods for preparing immunogenic, prophylactically and therapeutically effective complexes of heat shock proteins noncovalently associated with antigenic peptides of cancer cells. The claimed methods comprise the constructing of a cDNA library from cancer or preneoplastic cell RNA, expressing the cDNA library in an appropriate host cell, and recovering the immunogenic complexes from the cells. Large amounts of such immunogenic complexes can be obtained by large-scale culturing of host cells containing the cDNA library. The complexes can be used as a vaccine to elicit specific immune responses against cancer or preneoplastic cells, and to treat or prevent cancer.

DETAILED DESCRIPTION The present invention relates to methods for producing increased amounts of immunogenic material which can be used for prevention and treatment of cancer.
The immunogenic compositions prepared by the methods of the invention comprise noncovalently associated molecular complexes of a heat shock protein (hsp) and an antigenic (or immunogenic) peptide.
The complexes prepared by the methods of the invention are intracellularly produced complexes comprising hsps from a selected recombinant host cell and antigenic peptides expressed from cDNAs of a cancer cell; the antigenic peptides of the complex are thus representative of antigenic peptides found in such cancer cell.
The present invention provides methods for making a cDNA library from cancer cells, using the cDNA library to produce by recombinant DNA methods in host cells immunogenic hsp-peptide complexes that confer immunity to the cancer cells in an individual to which the complexes are administered.
Generally, the methods of the invention comprise obtaining (e.
g.
, isolating) cancer cells from one or more individuals, preparing RNA from the cancer cells, making cDNA from the RNA, introducing the cDNA into host cells, culturing the host cells so that the cancer-derived cDNAs are expressed, and purifying heat shock protein-peptide complexes from the host cells.
The cDNA prepared from cancer cell RNA, herein referred to as "cancer cDNA", is optionally amplified prior to introduction into a host cell for expression.
The cDNAs are optionally inserted into a cloning vector for replication purposes prior to expression.
The cDNAs are inserted into an expression vector or intrachromosomally integrated, operatively linked to regulatory element(s) such as a promoter, for purposes of expressing the encoded proteins in suitable host cells in vitro.
The cDNAs are introduced into host cells where they are expressed by the host cells, thereby producing intracellularly noncovalent complexes of hsps and peptides (including those peptides encoded by the cancer cDNAs)



Related patents
  Human genes and gene expression products V
OF THE INVENTION The invention relates to polynucleotides comprising the disclosed nucleotide sequences, to full length cDNA, mRNA genomic sequences, and genes ...
  Haptotactic peprides
The invention claimed is: 1. An isolated haptotactic peptide of 20 amino acids consisting of the amino acid sequence as set forth in SEQ ID NO:1, characterized in that ...
  Hepatitis C virus inhibitors
OF THE INVENTION Stereochemical definitions and conventions used herein generally follow McGraw-Hill Dictionary of Chemical Terms, S. P. Parker, Ed., McGraw-Hill Book C...
  Expression of recombinant glyoprotein B from herpes simplex virus
The nucleotide sequence and the amino acid sequence derived therefrom are provided for Herpes Simplex Virus ("HSV") glycoprotein B ("gB") for use in expression of the ...
  Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone
The invention claimed is: 1. A therapeutic agent or prophylactic agent for a disease requiring enhancement of nerve growth factor production, wherein the therapeutic ...
  In vitro packaging of adeno-associated virus DNA
It is an object of the present invention to provide a method for packaging a DNA substrate in an in vitro reaction to produce adeno-associated virus (AAV) particles ...
  Recombinant viral vector system
The present invention relates to the in vitro synthesis of a novel 165 basepair fragment of DNA which contains AAV ITR sequences and which can be synthesized in vitro ...
  Modified adeno-associated virus vector capable of expression from a novel promoter
This invention provides an adeno-associated viral vector comprising the inverted terminal repeat sequences of adeno-associated virus and a nucleic acid, wherein the ...
  Culturable mitochondrial cells with no nucleus, showing mitochondrial activity
OF THE INVENTION Hereinafter, the present invention will be described in detail. (1) Method of Producing the Cells of the Present Invention The present invention ...
  Antisense oligonucleotides inhibiting human bcl-2 gene expression
The invention provides oligodeoxynucleotides and methods for inhibiting growth of lymphoma or leukemia cells, that are types of lymphocytes. An antisense ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved